SCHOTT KAISHA has inaugurated its new pharmaceutical packaging plant in Jambusar, Gujarat. This greenfield investment of 20 million euros will see an increase in the company’s production capacity in India by 50 per cent to around 2.0 billion ampoules and vials per year.
“We see a steadily rising demand for locally manufactured primary packaging that meets the rising quality demands,” says Kairus Dadachanji, Managing Director, SCHOTT KAISHA, adding, “Our new state-of-the-art factory sets new standards in India. This investment will result in better quality opportunities for our customers. In other words, we will be helping the Indian pharma industry to achieve its own growth objectives.”
The new plant in Jambusar has 20 production lines for ampoules and 16 for vials, with scope for further expansion. Its fully automated production process uses high-end robotic feeding technology for tube-loading as well as high-precision camera inspection systems. World market leading SCHOTT FIOLAX tubes are used as base material. The facility is India’s first pharma packaging plant meeting global standards with an ISO 15378 certification. This underlines the company’s commitment to the international GMP standard.
“KAISHA’s deep market knowledge about India and SCHOTT’s world class technology create a perfect partnership,” emphasises Prof Udo Ungeheuer, Chairman, Board of Management of SCHOTT. The SCHOTT group is highly committed to its pharma business. Our continuous investments in India demonstrate our ambition. More than one hundred years of experience in setting the world’s highest technology standards turn us into the ideal partner for India’s ambitious and fast growing pharmaceutical industry,” he adds.
EP News Bureau – Mumbai